The New England Journal of Medicine (NEJM) published a study that shows Afinitor® (everolimus) tablets plus best supportive care (BSC) more than doubled progression-free survival (PFS), or time without tumor growth, versus placebo plus BSC in patients with advanced pancreatic neuroendocrine tumors (NET)[1].

The American Society of Anesthesiologists (ASA) has asked the US Food and Drug Administration (FDA), for the sake of patient safety, to work with foreign governments to allow for the importation of sodium thiopental (Pentothal, Hospira) because domestic production of the controversial agent ceased in 2009.

The US Food and Drug Administration (FDA) has released its latest list of drugs to monitor based on potential signs of serious risks or new safety information identified in the agency's Adverse Event Reporting System (AERS).

The quarterly watch list consists of 13 medications that treat a wide range of conditions, including cough, angina, diabetes, cancer, and bipolar disorder.

Karnataka’s  Department of Information Technology, Bio-Technology and Science & Technology,  Vision Group on Biotechnology and MM Activ Sci-Tech Communications have announced that the 11th edition of the annual  ‘Bangalore India Bio 2011’ will be held from May 4 to May 6, 2011 at the Bangalore International Exhibition Centre (BIEC) on Tumkur Road, Bangalore.

Medical researchers from The University of Texas Health Science Centre at Houston (UTHealth) presented new research results at the American Heart Association International Stroke Conference that demonstrated how MultiStem, a novel stem cell therapy being developed by Athersys, Inc. provided multiple benefits when administered in preclinical models of ischemic stroke.

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Vidyabharti Trust College of Pharmacy Umrakh was established in the year 2004 under the ages of Vidyabharti Trust with main object of visionary in the mission of quality pharmacy education.
The Vidyabharti Trust College is located on the way of Bardoli-mota road 3 kilometer away from bardoli and 34 kilometer away from surat in a lush green sprawling campus with sufficient infrastructure facilities.

The Mumbai University Institute of Chemical Technology, known earlier as UDCT is the most outstanding Institute of the University of Mumbai. This prestigious institute is a jewel in the crown of the University of Mumbai. It was founded on 4th August 1934 and was recently awarded the status of the Institute on 26th January 2002 and renamed MUICT.

Applications are invited from the eligible candidates for the post of Project Fellow. Details include

Name of Post : Project Fellow

[adsense:336x280:8701650588]

No of Post : One

Alembic Limited, with an established presence in the Indian pharma  industry has a proud, historical track record going back one hundred years. With a turnover in excess of Rs1000 crores today, Alembic Limited is one of India’s leading integrated pharmaceutical companies. We continue to enjoy leadership positions in antibiotics, anti-infective, anti-cough and also have significant worldwide presence in specialty therapeutic areas such as cardiology, neurology, diabetology, etc.

DIT is a leading technical institute offering Undergraduate and Postgraduate programmes in several streams of Engineering, IT, Management, Architecture and Pharmacy. This is the oldest self financed professional institute of uttarakhand which was established in the year 1998.

Umrao Hospitals is a 330 bedded Multi-speciality tertiary care institute which is slated to be North Mumbai’s largest health care project. It has been envisioned as a healthcare destination where patients receive care in a truly restorative environment. It will deliver hi-end clinical care across major medical specialties through comprehensive solutions including consultancy, diagnostics and therapy.

Shreya Group has interests in both pharmaceutical and biopharmaceutical products in key therapeutic segments. Currently, Shreya operates in Russia, CIS, India, South East Asia and African countries. The Group turnover for the year 2006 was US $ 581 million including US $ 85 million in India.

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation.
Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.

United Biotech has been a trend setter of new standards and is among the fastest growing companies in the Indian pharmaceutical Industry. In a span of 12 years it has established an enviable reputation and track record for adopting latest manufacturing technologies, introducing world-class quality of products, ground breaking Research & Development efforts in association with its foreign counterparts and for setting new standards of customer service.

Titan Laboratories Pvt.Ltd. is the one of select few Company in india with dedicated state of art WHO GMP facility for producing high quality Sustained and Modified Release Pellets, DC Granules& Taste Masked Granules. The plant is located in green belt of mahad industrial zone about 180Kms from mumbai. It is strategically located on well connected Mumbai-Goa Highway.

ROMSONS had been serving the medical fraternity and patient population since 1952 and we have emerged as the most preferred brand among the surgeons, anesthesiologists and many other specialists since its perception till date.
We could achieve such a good acceptance of our products because of our vast network and dedicated Sales & Marketing Team.